GNS Awarded $1.6M Phase II SBIR Grant for Cardiac Computer Simulation to Test Drug Safety
16th Nov 2006, 10:43 GMT
IBM Makes Contribution of Blue Gene Supercomputer Power and Expertise
Latest news from Cardiology News from StratCenter.com:
- Merck says new drug is safer than Vioxx
- WelChol and Ezetimibe Combination Therapy Provides Significant LDL-C Reductions
- Volcano Announces Clinical Review of Key Presentations From TCT 2006
- Most defibrillators buried with patients: study
- Esaote Harnesses TX Instruments DSPs to Deliver Next-Generation Medical Diagnostic Systems
- Cerenis Therapeutics Closes $53.5 mln Financing
- November 14th is World Diabetes Day
- Misonix to Conduct Q1 FYE 2007 Financial Results Conference Call and Web Cast
- Clinical Data and Diagene in Cardiac Channelopathy Test Distribution Agreement for Germany, Switzerland and Austria
- Study Provides Further Support for Cardiovascular Safety of OTC Doses of Naproxen Sodium